Consistently, the expression levels of M2-related tumor-supportive factors, VEGF-B, PDGF-α, and MMP-9, were determined to be significantly downregulated after RG@M-γ-CD treatment (Fig. 6e). This evidence concerns the gene VEGFB and neoplasm.